Search Results for: wsj

How is your state prioritizing coronavirus vaccine for those with Down syndrome?

ANCOR's helpful "Vaccine Prioritization At A Glance" The rollout of the coronavirus vaccine has received justified criticism for its inefficiency. One area of concern for those with Down syndrome and their caregivers are how their home state's plan prioritizes them for receiving the vaccine. Continue Reading

News

This page features a running list of news items with or without brief commentary. You are invited to share those items that you find interesting with me by tweeting them to [at]MarkWLeach, or submit a comment anywhere on the blog with a link to the news Continue Reading

What is the real worry about the newest prenatal testing for Down syndrome?

  I've been reviewing the recent Wall Street Journal report by Christopher Weaver on the new prenatal testing for Down syndrome. Weaver reports on questions raised by the new testing. The accompanying video to the report (available above) distills the worry down to a few simple statements. But are these statements the real worry with the new prenatal testing for Down syndrome? Continue Reading

What price to do prenatal testing right?

The recent Wall Street Journal report by Christopher Weaver on Non-Invasive Prenatal Screening (NIPS) included a number that suggests how much money is in the NIPS market. But what else should that money be going towards? Continue Reading

Non-NIPS tests for Down syndrome are “tarot cards”

Continuing the examination of Christopher Weaver's recent report on NIPS in the Wall Street Journal, one quote jumped off the page when I read it. Did you know that screening tests that are not NIPS are as helpful as "tarot cards"? Continue Reading

Worries about new prenatal screen for Down syndrome

Earlier this month, the Wall Street Journal published a report on worries being raised about the new prenatal screening testing for Down syndrome. What are these worries (and are these the only ones worth reporting on)? Continue Reading